AfricaRegulatory

African Pharmaceutical Regulatory Intelligence

PERINDOPRIL / AMLODIPINE

13 registrations across 3 African markets— 6 active

Markets with PERINDOPRIL / AMLODIPINE

Recent registrations

Brand / ProductMarketHolderStatusExpires
CO-THERAPRIL
Comprimé / 5 mg/5mg
🇹🇳TunisiaTHERAexpiredJul 2018
CO-THERAPRIL
Comprimé / 10 mg/5 mg
🇹🇳TunisiaTHERAexpiredJul 2018
CO-THERAPRIL
Comprimé / 10 mg/10mg
🇹🇳TunisiaTHERAexpiredFeb 2018
COVERAM
Comprimé / 10mg/ 10mg
🇹🇳TunisiaSERVIERexpiredJul 2012
COVERAM
Comprimé / 10mg/ 5mg
🇹🇳TunisiaSERVIERexpiredJul 2012
COVERAM
Comprimé / 5mg/ 5mg
🇹🇳TunisiaSERVIERexpiredJul 2012
COVERAM
Comprimé / 5mg/ 10mg
🇹🇳TunisiaSERVIERexpiredJul 2012
CO-THERAPRIL
comprime / 10 mg / 10 mg
🇸🇳SenegalTHERAactive
COVERAM 5MG/5MG
COMPRIME
🇲🇦Moroccoactive
COVERAM 10MG/5MG
COMPRIME
🇲🇦Moroccoactive
SEFAM PL
comprime / 10mg/10mg
🇸🇳SenegalSEFIER LIFE SCIENCE PVT LTDactive
COVERAM 10MG/10MG
COMPRIME
🇲🇦Moroccoactive
COVERAM 5MG/10MG
COMPRIME
🇲🇦Moroccoactive

PERINDOPRIL / AMLODIPINE in Africa — Regulatory Overview

PERINDOPRIL / AMLODIPINE is registered across 3 African markets with 13 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Tunisia, Morocco, Senegal. AfricaRegulatory refreshes this data daily from official government sources.

Of the 13 registrations, 6 (46%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.